We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




AI Diagnostic Tool Accurately Detects Valvular Disorders Often Missed by Doctors

By HospiMedica International staff writers
Posted on 12 Oct 2023
Print article
Image: The AI tool detects cardiac diseases that doctors often miss (Photo courtesy of 123RF)
Image: The AI tool detects cardiac diseases that doctors often miss (Photo courtesy of 123RF)

Doctors generally use stethoscopes to listen for the characteristic lub-dub sounds made by heart valves opening and closing. They also listen for less prominent sounds that indicate problems with these valves. But the human body is full of other noises, like the flow of blood, stomach rumblings, and breath sounds, which can easily mask the signs of valvular heart disease (VHD). Research reveals that only 44% of VHD cases are caught through regular stethoscope check-ups. This leads to delayed diagnoses, worsening health conditions for patients, and huge costs for the healthcare system. To improve on this, researchers have now developed a new diagnostic tool that uses a short burst of audio data to accurately identify VHD.

Researchers at Stevens Institute of Technology (Hoboken, NJ, USA) used a contact microphone to take 10-second sound vibrations directly from a patient's chest. This data was then analyzed by an AI model adapted from algorithms normally used in speech processing to separate overlapping voices. In this case, the algorithm works to isolate the specific sounds associated with different types of heart valve diseases. The AI system can quickly identify up to five different types of valvular issues in a single patient, even if more than one condition is present.

The AI tool can detect VHD with 93% sensitivity and 98% specificity, substantially reducing undiagnosed cases and limiting false positives. The results are given in a simple 5-digit code made of ones and zeros, indicating the presence or absence of specific VHD. What sets this diagnostic tool apart from previously used neural networks to detect VHD is the use of accelerometers instead of more complex and cumbersome machines. Not only is this technique more accurate, but it also has the potential for further refinement. The team aims to extend their approach to identify other cardiovascular conditions and hopes to integrate this technology into medical practices nationwide, making it easier to diagnose cardiac disorders.

“Most cases of VHD are missed because of human error — so we brought in AI to help the human,” explained Negar Ebadi, the principal investigator of the project. “Our current goal is to collect more data so we can begin to classify diseases by severity — so instead of showing that you have a particular valvular disorder, we could give a grade out of 10 describing how far the disease has progressed.”

Related Links:
Stevens Institute of Technology 

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Portable Single Breath DLCO Device
EasyOne Pro

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.